These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11127360)
1. Guidelines for the use of flecainide in patients with supraventricular arrhythmias. Smith W; Crozier I; McAlister H; O'Meeghan T; Stewart F N Z Med J; 2000 Oct; 113(1119):420-1. PubMed ID: 11127360 [No Abstract] [Full Text] [Related]
2. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia. Campbell JQ; Best TH; Eswaran H; Lowery CL Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496 [TBL] [Abstract][Full Text] [Related]
3. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995. Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386 [No Abstract] [Full Text] [Related]
4. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias. Wehling M Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773 [TBL] [Abstract][Full Text] [Related]
5. [Drug therapy in supraventricular arrhythmia]. Follath F; Candinas R; Meyer B Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845 [TBL] [Abstract][Full Text] [Related]
6. Flecainide as first-line treatment for supraventricular tachycardia in newborns. Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276 [TBL] [Abstract][Full Text] [Related]
7. Neonatal flecainide toxicity following supraventricular tachycardia treatment. Hall CM; Ward Platt MP Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523 [No Abstract] [Full Text] [Related]
9. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology]. Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960 [No Abstract] [Full Text] [Related]
10. Use of maternal flecainide concentration in management of fetal supraventricular tachycardia: a step in the right direction. Cuneo BF; Benson DW Heart Rhythm; 2014 Nov; 11(11):2054-5. PubMed ID: 25128734 [No Abstract] [Full Text] [Related]
11. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Krapp M; Baschat AA; Gembruch U; Geipel A; Germer U Ultrasound Obstet Gynecol; 2002 Feb; 19(2):158-64. PubMed ID: 11876808 [TBL] [Abstract][Full Text] [Related]
12. Refractory Fetal Supraventricular Tachycardia with Hydrops Successfully Converted by Intraperitoneal Flecainide in the Fetus: A Case Report. Vedel C; Vejlstrup N; Jensen LN; Ekelund CK; Nørgaard LN; Harmsen L; Petersen OB; Jaeggi E; Gembruch U; Sundberg K Fetal Diagn Ther; 2020; 47(9):717-720. PubMed ID: 32570238 [TBL] [Abstract][Full Text] [Related]
13. An enhancement of coronary blood flow in a fetus with supraventricular tachycardia. Uerpairojkit B; Manotaya S; Tanawattanacharoen S; Prechawat S; Charoenvidhya D Prenat Diagn; 2009 Mar; 29(3):274-6. PubMed ID: 19165830 [No Abstract] [Full Text] [Related]
14. Supraventricular tachycardia with hydrops in a 27-week premature baby. Abraham P Int J Clin Pract; 2001 Oct; 55(8):569-70. PubMed ID: 11695082 [TBL] [Abstract][Full Text] [Related]